Abstract
Although patients with high-grade upper tract urothelial cancer are routinely managed with radical nephroureterectomy, some subsets of patients with low-grade disease might initially be offered renal-sparing approaches such as endoscopic ablation, even though many of these patients will ultimately require radical nephroureterectomy. Because this disease is most common in patients aged 60 years and older, better therapeutic options than this high-risk surgery need to be introduced to bring nephron-sparing approaches into clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.